Bone Biologics Corp. (BBLG)

NASDAQ

$0.42

$-0.03

(-6.11%)

After-Hours

Bone Biologics Corp. (BBLG) Live Price Chart

Last updated: ⁦2026-10-13 21:26:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Bone Biologics Corp. (BBLG) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $0.42, with a market capitalisation of $1.29M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.41 to $2.76. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.29M
Open	$0.44
Day's High	$10,255.54
Day's Low	$0.41
Previous Close	$0.46
Volume	59.59K
Average Volume	383.49K
P/E Ratio	--
52-Week High	$2.76
52-Week Low	$0.41
Dividend Yield	--
Earnings Date	--

Bone Biologics Corp. (BBLG) After-Hours Stock Price

Bone Biologics Corp. (BBLG) is trading at $0.42 in after-hours trading as of 2026-10-13 20:00:00, down 8.81% ($0.04) from the regular-session close of $0.46.

After-hours trading shows how investors are pricing BBLG after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Bone Biologics Corp. (BBLG) 7-Day Stock Price Change

Over the past seven days, Bone Biologics Corp. (BBLG) moved from $0.48 to $0.42, representing a decline of 12.71% ($0.06).

The stock traded between $0.41 and $0.50 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 28.56 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BBLG 52-Week Price Position

Position in Range: 0.3%

52W Low$0.41

52W High$2.76

BBLG is currently trading at $0.42, placing it 0.3% of the way from its 52-week low of $0.41 to its 52-week high of $2.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bone Biologics Corp. (BBLG)?

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Bone Biologics Corp. Information

Industry	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Employees	2
Exchange	NASDAQ
Company Website	https://www.bonebiologics.com

How to Buy Bone Biologics Corp. (BBLG) Stock on MEXC

Eligible investors can buy real shares of Bone Biologics Corp. (BBLG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BBLG and Place Your Order

Open the RealStocks trading page and search for BBLG. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bone Biologics Corp. (BBLG) stock price today?

Bone Biologics Corp. (BBLG) is currently trading at $ 0.42, down 8.81% ($0.04) from the previous close of $ 0.46. Intraday prices update in real time during regular trading hours.

2.Is BBLG stock going up or down today?

As of 2026-10-13 20:00:00, BBLG is trading at $ 0.42, down 8.81% ($0.04) from its previous close of $ 0.46. The stock has traded between $ 0.41 and $ 10,255.54 during today’s regular session. Past price movements do not guarantee future results.

3.What is BBLG pre-market price?

As of 2026-10-13 20:00:00, BBLG is trading at $ 0.47 in pre-market trading, up 3.27% ($0.01) from the previous close of $ 0.46. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BBLG after-hours price?

As of 2026-10-13 20:00:00, BBLG is trading at $ 0.42 in after-hours trading, down 8.81% ($0.04) from the regular-session close of $ 0.46. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BBLG stock trading now?

BBLG trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BBLG sit relative to its 52-week high and low?

Over the past 52 weeks, BBLG has traded between a low of $ 0.41 and a high of $ 2.76. At $ 0.42, the stock is positioned 0.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bone Biologics Corp. in?

Bone Biologics Corp. (BBLG) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bone Biologics Corp.'s market capitalisation and where is it listed?

Bone Biologics Corp. is listed on the NASDAQ exchange with a market capitalisation of $ 1.29M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BBLG valued in terms of P/E ratio and EPS?

BBLG trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.05. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bone Biologics Corp. pay a dividend?

Bone Biologics Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.